Long-Term SHIV Suppression Using AAV Gene Therapy
Leronlimab is an antiviral HIV drug that targets and blocks the CCR5 receptor, thus blocking HIV’s ability to invade immune cells. Most macaques that produced sufficient number of antibodies showed long-term partial or full suppression of SHIV. The post Long-Term SHIV Suppression Using AAV Gene Therapy appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.